Tanaka T - Search Results

1

Immunoreactive somatomedin C/insulin-like growth factor I in urine from normal subjects, pituitary dwarfs, and acromegalics.

Yokoya S, Suwa S, Maesaka H, Tanaka T. Yokoya S, et al. Among authors: tanaka t. Pediatr Res. 1988 Feb;23(2):151-4. doi: 10.1203/00006450-198802000-00002. Pediatr Res. 1988. PMID: 3353157

2

Age, sex and growth hormone dependent changes in urinary IGF-I.

Yokoya S, Suwa S, Maesaka H, Tanaka T. Yokoya S, et al. Among authors: tanaka t. Acta Paediatr Scand Suppl. 1988;347:134-5. Acta Paediatr Scand Suppl. 1988. PMID: 3254028 No abstract available.

3

Clinical usefulness of urinary growth hormone measurement in short children.

Tanaka T, Yoshizawa A, Miki Y, Ito J, Tanaka M, Tanae A, Yokoya S, Hibi I. Tanaka T, et al. Among authors: tanaka m. Acta Paediatr Scand Suppl. 1990;366:155-8. doi: 10.1111/j.1651-2227.1990.tb11621.x. Acta Paediatr Scand Suppl. 1990. PMID: 2403005

4

Analysis of linear growth during puberty.

Tanaka T, Suwa S, Yokoya S, Hibi I. Tanaka T, et al. Acta Paediatr Scand Suppl. 1988;347:25-9. Acta Paediatr Scand Suppl. 1988. PMID: 3254033

5

Changes in somatomedin activity in anorexia nervosa.

Tanaka T, Maesaka H, Suwa S. Tanaka T, et al. Endocrinol Jpn. 1985 Dec;32(6):891-7. doi: 10.1507/endocrj1954.32.891. Endocrinol Jpn. 1985. PMID: 3833530 Free article.

6

A dose finding study of a super long-acting luteinizing hormone-releasing hormone analog (leuprolide acetate depot, TAP-144-SR) in the treatment of central precocious puberty. The TAP-144-SR CPP Study Group.

Tanaka T, Hibi I, Kato K, Saito S, Shimizu N, Suwa S, Nakajima H. Tanaka T, et al. Endocrinol Jpn. 1991 Aug;38(4):369-76. doi: 10.1507/endocrj1954.38.369. Endocrinol Jpn. 1991. PMID: 1839379 Free article. Clinical Trial.

7

Age-related changes in IGF I/SmC levels in plasma and urine--glomerular filtration of the unbound form.

Yokoya S, Suwa S, Maesaka H, Tanaka T. Yokoya S, et al. Among authors: tanaka t. Acta Paediatr Jpn. 1988;30 Suppl:50-4. Acta Paediatr Jpn. 1988. PMID: 3146877 No abstract available.

8

Clinical utility of insulin-like growth factor binding protein-3 in the evaluation and treatment of short children with suspected growth hormone deficiency.

Hasegawa Y, Hasegawa T, Aso T, Kotoh S, Nose O, Ohyama Y, Araki K, Tanaka T, Saisyo S, Yokoya S, et al. Hasegawa Y, et al. Among authors: tanaka t. Eur J Endocrinol. 1994 Jul;131(1):27-32. doi: 10.1530/eje.0.1310027. Eur J Endocrinol. 1994. PMID: 7518726

9

[Serum levels of intact molecular osteocalcin in children with growth hormone (GH) deficiency during GH therapy: an early predictor of GH therapy].

Seino Y, Kanzaki S, Kubo T, Hibi I, Tanaka T, Suwa S, Tachibana K, Okuno A, Niimi H, Tsuchiya Y, et al. Seino Y, et al. Among authors: tanaka t. Nihon Naibunpi Gakkai Zasshi. 1994 Dec 20;70(10):1063-74. doi: 10.1507/endocrine1927.70.10_1063. Nihon Naibunpi Gakkai Zasshi. 1994. PMID: 7859886 Japanese.

10

Serum levels of 20-kilodalton human growth hormone (GH) are parallel those of 22-kilodalton human GH in normal and short children.

Ishikawa M, Yokoya S, Tachibana K, Hasegawa Y, Yasuda T, Tokuhiro E, Hashimoto Y, Tanaka T. Ishikawa M, et al. Among authors: tanaka t. J Clin Endocrinol Metab. 1999 Jan;84(1):98-104. doi: 10.1210/jcem.84.1.5402. J Clin Endocrinol Metab. 1999. PMID: 9920068

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,369 results

Search Page

Filters